| Type | Title | Date Released | |
|---|---|---|---|
6-K | Charming Medical Limited Announces Nasdaq Delisting Determination and Suspension of Trading New | ||
6-K | Charming Medical Limited Receives Nasdaq Delisting Determination Notice | ||
6-K | Notice of Extraordinary General Meeting for Charming Medical Limited to Approve Cancellation of Class B Shares and Removal of Dual-Class Structure | ||
20-F | Form 20-F | ||
6-K | Charming Medical Limited Announces Corporate Governance Enhancements and Abolition of Dual-Class Share Structure | ||
6-K | Charming Medical Limited Announces Board of Directors Changes | ||
6-K | Charming Medical Limited Appoints Matthew Mo Kan Tsui as Independent Director | ||
6-K | Charming Medical Limited Unaudited Interim Financial Results for the Six Months Ended September 30, 2025 | ||
6-K | Charming Medical Limited Announces Resignation of Independent Director | ||
SCHEDULE 13D | Wong Kit Christine (Filed by) | ||
3 | YU SHU TAI VICTOR (Reporting) | ||
3 | Wong Kit Christine (Reporting) |